
Strategy & Forecasting Consultant with 4.5+ years of experience in pharmaceutical commercial analytics, specializing in immuno-oncology forecasting for a ~$16B portfolio. Proven expertise in patient-based and Rx-based forecasting, pipeline/launch strategy, and market intelligence. Strong track record of driving data-driven decision-making for global stakeholders, improving forecast accuracy (~15%), and accelerating planning cycles (~20). Experienced in working with cross-functional teams across Commercial, Finance, and Market Research.